Association between Sleep, Alzheimer’s, and Parkinson’s Disease
The majority of neurodegenerative diseases are pathologically associated with protein misfolding and aggregation. Alzheimer’s disease (AD) is a type of dementia that slowly affects memory and cognitive function, and is characterized by the aggregation of the β-amyloid protein and tau neurofibrillary...
Saved in:
Main Authors: | Sumire Matsumoto, Tomomi Tsunematsu |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d527a4a5904e4e9784cae55e7bc4a2e5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
by: Guo YJ, et al.
Published: (2016) -
Liposome delivery systems for the treatment of Alzheimer’s disease
by: Ross C, et al.
Published: (2018) -
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
by: Vyronia Vassilakopoulou, et al.
Published: (2021) -
Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
by: Javdani N, et al.
Published: (2019) -
Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
by: Alimohammadi E, et al.
Published: (2020)